Skadden is representing Algeta ASA, a Norwegian pharmaceutical company specializing in cancer therapies, in its $2.9 billion acquisition by Aviator Acquisition AS, a subsidiary of Bayer Nordic SE, announced on December 19.

BACK TO TOP